Duke Diabetes Mellitus and Cardiovascular Disease Symposium
A variety of recent developments in the field of diabetes and CV disease, including new insights into the pathophysiology of important complications, novel drugs, and changes in the process of care all necessitate ongoing efforts to improve education among clinicians. As professional societies have not yet fully incorporated this rapidly evolving body of knowledge into diabetes care guidelines, it is imperative that physicians and other providers be armed with the most up-to-date evidence to help their patients make the best possible treatment decisions.
cardiologists, endocrinologists, primary care physicians, advanced practice providers
- Review and discuss best practices for reducing the risk of atherosclerotic cardiovascular complications in patioents with diabetes mellitus
- Describe the importance of modification of glycemic targets in patients with diabetes, considering key clinical factors such as established comorbidities and hypoglycemia risk.
- Understand the rationale for and finding from recent cardiovascular outcomes trials designed to assess the sasfety of new medicatons for diabetes mellitus
- Delineate the possible role of new anti-hyperglycemic agents in the care of high cardiovascular risk patients with diabetes.
- Understand the interaction of heart failure with comorbidities such as diabetes and coronary artery disease.
- Describe the current state of the art of heart failure management, and in particular clinical considerations in patients with diabetes.
- Review best practices for when to refer high cardiovascular risk patients with diabetes for evaluation in subspecialty care clinics.
Robert Mentz, MD
Jennifer Green, MD
David D'Alessio, MD
Christopher Granger, MD
G. Michael Felker, MD, MHS, FACC, FAHA
Bray Patric-Lake, MFS
Robert Califf, MD
Darren McGuire, MD, MHSc
Eric Peterson, MD, MPH
- 4.75 Attendance